Clinical Trial Search

Primary: Change in CBF From Baseline (Before Start of the Hemodialysis Study Session), at 20 Minutes, and at the End of the Hemodialysis Study Session, Measured by [15O]H2OPET-CT…

Primary: Titers for Serum Hemagglutination Inhibition (HI) Antibodies Against A/California/7/2009 (H1N1)V-like Antigen — 8.8 Titers

Primary: Number of Patients With a Diagnosis of Gestational Diabetes at 26 Weeks Gestation. — 19; 23 Participants — p=0.32

Primary: Part B: PASI (Psoriasis Area and Severity Index) Score Mean Percentage of Change Through Day 43 — 19.88; 17.74; 53.57; 86.04 percentage improvement

Primary: Mean Change in Best Corrected Visual Acuity (BCVA) as Measured by Early Treatment of Diabetic Retinopathy Study (ETDRS) Letter Scores From Baseline to Week 52 - Last…

Primary: Number of Subjects With Immediate Adverse Events — 0; 0 Participants

Primary: Change in Methane Production — 10645; 14635 parts per million*minutes

Primary: Number of Participants With Successful Cannulation of the Internal Jugular Vein — 34 Participants

Primary: Number of Subjects With Adverse Events (AEs) — 8; 4; 1; 1 Participants

Primary: Change in Total Body Fat (kg). — 0.15; -1.77; -1.27 change in kilograms — p=0.03

Primary: Number of Participants Who Experience at Least One Adverse Drug Reactions (ADRs) — 94 Participants

Primary: Proportion of Patients With a Severe Asthma Exacerbation During 14 Days of Treatment — 7; 5 Participants — p=0.645

Primary: Number of Subjects With Anti-pneumococcal Serotypes 1, 4, 5, 6B, 7F, 9V, 14, 18C, 19F and 23F Antibody Concentrations >= 0.20 Microgram Per Milliliter (µg/mL)…

Primary: Number of Participants With Detected Proximal Diminutive (<10 mm) Adenoma Detection Rate — 86; 89; 83; 38 participants

Primary: Response Conversion Rate — 8 Participants